Health Care·Pharmaceuticals·$49.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.20 | N/A | -1.96% |
management commentary, guidance changes, and full analysis available with Pro.
| -1.96% |
Tone: Defensive
Overall, management conveyed a cautious outlook, highlighting the need to navigate ongoing market pressures. They did not provide specific guidance for future performance.
Management acknowledged challenges in the current market environment.
They emphasized a focus on maintaining operational efficiency.
The earnings report indicates that Zoetis Inc faced challenges, leading to a slight miss on EPS expectations. The stock reacted negatively, dropping 3.25% in response to the cautious tone from management and the lack of specific guidance for the future. Investors may be concerned about the company's ability to navigate current market conditions.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MONOLITHIC PWR SYS I
Aug 1, 2022